FDA weighs in to improve generic competition
June 27, 2017Medical Communications, Sales and Marketing FDA, generic drugs, pricing debate
Since Scott Gottlieb was appointed Commissioner, the FDA has been on a marked push to tackle two areas: drug pricing …
Novo Nordisk’s diabetes drug recommended for expanded indication in Europe
June 27, 2017Research and Development, Sales and Marketing CHMP, EMA, EU, Novo Nordisk, Victoza
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has given its recommendation to expand the indication of Novo …
New potential blockbuster RA treatment enters European market
June 27, 2017Sales and Marketing AbbVie, Humria, Kevzara, Regeneron, Sanofi
The world’s biggest selling drug, AbbVie’s Humira with $16 billion in sales last year, has a new rival in the …
Biogen appoint new Head of Global Therapeutic Operations
June 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Jean-Paul Kress
Biogen announced that Jean-Paul Kress has been appointed to the position of Executive Vice President and President, International, and Head …
UK launch of two Novartis biosimilars could cut NHS costs
June 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erelzi, Novartis, Rixathon, Sandoz, biosimilar, etanercept, rituximab
Sandoz, a division of Swiss pharma giant Novartis, has revealed that two of its biosimilars – Rixathon (biosimilar rituximab) and …
Number of patients at risk from NHS mail mistake revealed
June 27, 2017Manufacturing and Production, Medical Communications Department of Health, Jeremy Hunt, NHS, NHS England
According to the patient records that have been examined so far, at least 1,700 may have been put at risk …
Duchenne drug made available to UK patients early
June 27, 2017Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, Raxone
UK patients will be given access to Santhera Pharmaceutical’s Duchene Muscular Dystrophy (DMD) drug, Raxone (idebenone), through the Early Access …
The July/August 2017 issue of Pharmafocus is now live!
June 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus
The July/August edition of Pharmafocus is now available – click here to read online.
Therapy able to block both opioid high and withdrawal
June 26, 2017Manufacturing and Production, Research and Development Camurus, buprenorphine
A study into an injectable form of buprenorphine treatment for opioid abuse has found that the formulation is able to …
Drug Combinations and Emerging Interactions
June 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug combinations, drug resistance, feature
Pamela Yeh, Assistant Professor at the Department of Ecology and Evolutionary Biology, University of California, Los Angeles, discusses how drug …
Humira set to face new European biosimilar rival
June 26, 2017Sales and Marketing CHMP, EMA, Samsung Bioepis
A position opinion from the EMA for Samsung Bioepis’ biosimilar of Humira looks set to unleash a second rival to …
Roche haemophilia therapy cuts bleed rate by 87%
June 26, 2017Research and Development, Sales and Marketing Roche, haemophilia
Roche has revealed new data on its investigational haemophilia therapy ACE910 (emicizumab) which shows an 87% reduction in bleed rate …
Public dissatisfaction with NHS found to be growing, says BMA
June 26, 2017Medical Communications, Sales and Marketing BMA, NHS
The British Medical Association has revealed that a poll, conducted by British doctors, shows that levels of public dissatisfaction with …
Promising Phase 2 obesity data for Novo’s diabetes drug
June 26, 2017Research and Development, Sales and Marketing Novo Nordisk
Novo Nordisk is hopeful about the prospects of its diabetes drug semaglutide as a treatment for obesity after it produced …
Astellas receives further year suspension from ABPI
June 26, 2017Medical Communications, Sales and Marketing ABPI, Astellas
The Association of the British Pharmaceutical Industry (ABPI) has announced that it has taken the unusual step of extending the …
Woodley Equipment Attending Outsourcing in Clinical Trials UK & Ireland 2017
June 23, 2017Woodley Equipment is attending Outsourcing in Clinical Trials UK and Ireland Conference taking place at the Royal Garden Hotel, London …
Pfizer’s biosimilar gets a second knock-back from FDA
June 23, 2017Medical Communications, Sales and Marketing Amgen, Epogen, FDA, Pfizer
Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the …
Novartis lung cancer combo receives FDA approval
June 23, 2017Medical Communications, Sales and Marketing NSCLC, Novartis
Novartis has revealed that its drug Tafinlar (dabrafenib) has received approval from the FDA for use in combination with Mekinist …
HIV cases in gay men fall for the first time in England
June 23, 2017Medical Communications HIV, PrEP
For the first time in English history, new diagnoses of HIV have fallen across the country – the drop was …
Rare cancers through the looking glass
June 23, 2017Medical Communications, Research and Development pharmafile, rare cancer
Rare cancers are not so rare after all. According to the organisation Rare Cancer Europe more than 4.3 million people …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
